Gallbladder and pancreas problems on GLP-1 medicines: warning signs

The gallbladder stores bile and releases it when you eat. Rapid weight loss changes the composition of bile, making gallstones more likely, and these medicines also slow gallbladder emptying in some people. Gallstones can cause pain, inflammation of the gallbladder or blockage of the bile duct. The pancreas produces digestive enzymes and insulin, and rare cases of pancreatitis have been reported in people taking these drugs, though the exact relationship is still being studied.

• Pain in the upper right abdomen or just below the breastbone, often after fatty meals.

• Pain that lasts for hours, and may spread to the right shoulder or back.

• Nausea and vomiting with the pain.

• Fever and chills, which may mean infection.

• Yellowing of the skin or eyes, dark urine and pale stools, which can indicate a blocked bile duct.

Typical features are severe, constant pain in the upper abdomen that often radiates to the back, nausea and vomiting, tenderness of the abdomen and sometimes fever or a fast heartbeat. The pain is usually worse than ordinary stomach upset and does not ease with simple measures. If you have severe abdominal pain with vomiting, seek emergency care through 999 or A&E and do not take another dose.

Clinicians examine the abdomen and often arrange blood tests, including pancreatic enzymes such as amylase or lipase, liver tests and inflammatory markers. An ultrasound scan can look for gallstones and a thickened gallbladder wall; CT or MRI may be used if pancreatitis or complications are suspected. Treatment may involve fluids, pain relief and sometimes surgery to remove the gallbladder.

Slower and steadier weight loss is gentler on the gallbladder. Avoid crash diets and extremely low-fat intake, which reduce gallbladder contraction. Tell your prescriber if you have a history of gallstones or pancreatitis, high triglycerides or heavy alcohol use before treatment begins, because these affect the risk-benefit balance.

If you develop either condition, tell your prescriber and report it through the MHRA Yellow Card scheme. Make sure the event is recorded in your medical notes so any future prescriber is aware. Whether the medicine can ever be restarted is a specialist decision.

Most abdominal symptoms on these medicines turn out to be ordinary digestive upset, and most people never develop gallbladder or pancreatic disease. The aim of knowing the warning signs is not to cause anxiety but to make sure that the minority who do need urgent help receive it quickly, because early treatment generally leads to better outcomes.